Beijing Inno Medicine Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2016-11-15
- Employees
- -
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)YN001-004 in Patients With Coronary Atherosclerosis in Australia
Phase 2
Recruiting
- Conditions
- Coronary Artery DiseaseCoronary Atherosclerotic Disease
- Interventions
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Beijing Inno Medicine Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06700720
- Locations
- 🇦🇺
Canberra Hospital, Canberra, Australian Capital Territory, Australia
🇦🇺Albury Wodonga Private Hospital, Albury, New South Wales, Australia
🇦🇺Core Research Group Pty Ltd, Milton, Queesland, Australia
YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
Phase 1
Completed
- Conditions
- Atherosclerotic Cardiovascular Disease
- Interventions
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Beijing Inno Medicine Co., Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT06048588
- Locations
- 🇨🇳
Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Peking University first hospital, Beijing, Beijing, China
🇨🇳Renmin Hospital of Wuhan University, Wuhan, Hubei, China
A First-in-human Study of YN001 in Healthy Volunteers
- First Posted Date
- 2022-12-02
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Beijing Inno Medicine Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT05635084
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
News
No news found